foxo4-dri senolytic peptide human trial 2024 foxo4 dri 2025 alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Dose:5 mg dihexa effects Peptide in Regenerative Support – laboratory research only Amount:70mg orlando dihexa therapy Intensive
Pay in 4 interest-free payments of $6.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2